{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:13:26Z","timestamp":1790345606890,"version":"4.1.0"},"reference-count":91,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Research Deputy of Yasuj University of Medical Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Given the significant impact of depression, sexual function, and health-related quality of life (HRQOL) in women with Polycystic Ovarian Syndrome (PCOS), it is crucial to identify scientifically supported interventions that enhance these outcomes and thereby promote HRQOL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>The present study aimed to assess the effect of adjutant administration of Sildenafil plus Melatonin on psycho-sexual status in PCOS women undergoing Metformin in an Iranian population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study was a randomized clinical trial. 216 Eligible women were assigned to four groups including Sildenafil plus Metformin, Melatonin plus Metformin, Melatonin plus Sildenafil and Metformin, and Metformin alone. The duration of intervention was 3 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>The Female Sexual Function Index, Hospital Anxiety and Depression Scale and modified PCOS health-related QOL questionnaire were used to evaluate sexual function, severity of depression and HRQOL, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Based on the results of the present study, statistically significant improvement was found in menstrual cyclicity, sexual function (desire and arousal), HRQOL concerning menstrual and emotional aspects and severity of depression between the groups before and after the intervention in Sildenafil plus Melatonin compared to other groups after 3 months (P\u00a0&amp;lt;\u20090.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>The present research determined administration of Sildenafil plus Melatonin enhances menstrual cyclicity status, mental well-being, sexual function, and HRQOL in women with PCOS who undergoing Metformin treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths &amp; Limitations<\/jats:title>\n                  <jats:p>The current research possesses several strengths, notably its adherence to the rigorous standards of a randomized controlled trial with well-defined initial inclusion criteria. In addition, this questionnaire is based on the previously ratified tools used. A robust sample size was maintained, enhancing the statistical power of the analysis. However, all the sample participants were sourced from a university referral clinic. Additionally, due to cultural norms, every participant in this study was married. Lastly, the absence of a post-intervention follow-up period is a notable gap; such a period could help determine the duration of the clinical effects or assess if ongoing treatment with Sildenafil plus Melatonin is necessary to sustain these effects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Findings from this initial randomized controlled trial indicate that a 12-week administration of Sildenafil plus Melatonin could enhance menstrual cyclicity status, reduce depression severity, and sexual function as well as HRQOL in women with PCOS who undergoing Metformin.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdaf028","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T13:42:51Z","timestamp":1742391771000},"page":"813-824","source":"Crossref","is-referenced-by-count":1,"title":["Improved psychosexual wellbeing with administration of combined Sildenafil plus Melatonin compared than either drug alone in management of women with polycystic ovarian syndrome: a 3-month randomized clinical study"],"prefix":"10.1093","volume":"22","author":[{"given":"Zahra","family":"AsadiKalameh","sequence":"first","affiliation":[{"name":"Department of Gynecology and obstetrics, Faculty of Medicine, Yasuj University of Medical Sciences , Yasuj ,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Abbasi","sequence":"additional","affiliation":[{"name":"Department of Gynecology and obstetrics, Faculty of Medicine, Yasuj University of Medical Sciences , Yasuj ,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed-Abdolvahab","family":"Taghavi","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Research Center, Yasuj University of Medical Sciences , Yasuj ,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Bazarganipour","sequence":"additional","affiliation":[{"name":"Department of Midwifery , Faculty of Medicine, , Yasuj ,","place":["Iran"]},{"name":"Yasuj University of Medical Sciences , Faculty of Medicine, , Yasuj ,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"2025051303321543200_ref1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejogrb.2017.04.045","article-title":"Evaluation of the quality of life of pregnant women from 2005 to 2015","volume":"214","author":"Morin","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025051303321543200_ref2","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-78665-0_21","volume-title":"Handbook of Disease Burdens and Quality of Life Measures","author":"Lam","year":"2010"},{"issue":"5","key":"2025051303321543200_ref3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.fertnstert.2013.06.043","article-title":"Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach","volume":"100","author":"Bazarganipour","year":"2013","journal-title":"Fertil Steril"},{"issue":"9","key":"2025051303321543200_ref4","first-page":"753","article-title":"Iranian version of modified polycystic ovary syndrome health-related quality of life questionnaire: discriminant and convergent validity","volume":"11","author":"Bazarganipour","year":"2013","journal-title":"Iran J Reprod Med"},{"issue":"12","key":"2025051303321543200_ref5","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"9588","key":"2025051303321543200_ref6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"2025051303321543200_ref7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/0959353500010001013","article-title":"The experiences of women with polycystic ovarian syndrome","volume":"10","author":"Willmott","year":"2000","journal-title":"Feminism Psychol"},{"issue":"3","key":"2025051303321543200_ref8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0277-9536(01)00034-X","article-title":"The thief of womanhood\u2019: women\u2019s experience of polycystic ovarian syndrome","volume":"54","author":"Kitzinger","year":"2002","journal-title":"Soc Sci Med"},{"key":"2025051303321543200_ref9","volume-title":"America's Children: Key National Indicators of Well-Being, 2009 (National Center for Health)","author":"Federal Interagency Forum on Child and Family Statistics","year":"2009"},{"key":"2025051303321543200_ref10","first-page":"673","article-title":"The polycystic ovary syndrome-a medical condition but also an important psychosocial problem","volume":"25","author":"Eggers","year":"2001","journal-title":"Coll Anthropol"},{"key":"2025051303321543200_ref11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/dhps.s4388","article-title":"Polycystic ovary syndrome and its impact on women's quality of life: more than just an endocrine disorder","volume":"1","author":"Brady","year":"2009","journal-title":"Drug Healthc Patient Saf"},{"issue":"1","key":"2025051303321543200_ref12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"ESHRE\/ASRM: ESHRE\/ASRM Rotterdam Consensus Meeting","year":"2004","journal-title":"Hum Reprod"},{"issue":"11","key":"2025051303321543200_ref13","doi-asserted-by":"publisher","first-page":"CD003053","DOI":"10.1002\/14651858.CD003053.pub6","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Morley","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2025051303321543200_ref14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0010-7824(85)90042-3","article-title":"Indian Council of Medical Research. Task force on hormonal contraception: phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive","volume":"32","author":"Baweja","year":"1985","journal-title":"Contraception"},{"issue":"5","key":"2025051303321543200_ref15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.freeradbiomed.2012.06.031","article-title":"Inorganic nitrite stimulates pancreatic islet blood flow and insulin secretion","volume":"53","author":"Nystr\u00f6m","year":"2012","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"2025051303321543200_ref16","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1161\/01.ATV.0000107028.20478.8e","article-title":"Insulin stimulates glucose transport via nitric oxide\/cyclic GMP pathway in human vascular smooth muscle cells","volume":"23","author":"Bergandi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"171","key":"2025051303321543200_ref17","doi-asserted-by":"publisher","first-page":"230183","DOI":"10.1183\/16000617.0183-2023","article-title":"The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase","volume":"33","author":"Benza","year":"2024","journal-title":"Eur Respir Rev"},{"issue":"4","key":"2025051303321543200_ref18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2337\/db06-0883","article-title":"Chronic treatment with sildenafil improves energy balance and insulin action in high fat\u2013fed conscious mice","volume":"56","author":"Ayala","year":"2007","journal-title":"Diabetes"},{"issue":"12","key":"2025051303321543200_ref19","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1210\/jc.2015-3415","article-title":"Treatment with sildenafil improves insulin sensitivity in prediabetes: a randomized, controlled trial","volume":"100","author":"Ramirez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025051303321543200_ref20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2337\/dc08-1862","article-title":"Phosphodiesterase 5 inhibition improves \u03b2-cell function in metabolic syndrome","volume":"32","author":"Hill","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"2025051303321543200_ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7078108","article-title":"Advantages of phosphodiesterase type 5 inhibitors in the Management of Glucose Metabolism Disorders: a clinical and translational issue","volume":"2020","author":"Antinozzi","year":"2020","journal-title":"Int J Endocrinol"},{"issue":"3","key":"2025051303321543200_ref22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/s0090-4295(98)00633-5","article-title":"Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction","volume":"53","author":"Kaplan","year":"1999","journal-title":"Urology"},{"issue":"4","key":"2025051303321543200_ref23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/152460902317586001","article-title":"Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder","volume":"11","author":"Basson","year":"2002","journal-title":"J Womens Health Gend Based Med"},{"issue":"5 Suppl","key":"2025051303321543200_ref24","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.5664\/jcsm.26932","article-title":"Melatonin and its receptors: a new class of sleep-promoting agents","volume":"3","author":"Doghramji","year":"2007","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"2025051303321543200_ref25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1046\/j.1365-2826.2003.00989.x","article-title":"Role of melatonin in the regulation of human circadian rhythms and sleep","volume":"15","author":"Cajochen","year":"2003","journal-title":"J Neuroendocrinol"},{"issue":"12","key":"2025051303321543200_ref26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.18502\/ijrm.v17i12.5789","article-title":"The role of melatonin in polycystic ovary syndrome: a review","volume":"17","author":"Mojaverrostami","year":"2019","journal-title":"IJRM"},{"issue":"10","key":"2025051303321543200_ref27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fendo.2019.00273","article-title":"Effects of melatonin supplementation on hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome","volume":"10","author":"Jamilian","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2025051303321543200_ref28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006105.pub4","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","volume":"2020","author":"Tso","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"2025051303321543200_ref29","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferrimanm","year":"1961","journal-title":"J Clin Endocrinol Metab."},{"key":"2025051303321543200_ref30","first-page":"218","volume-title":"Acne Vulgaris. Histopatbology of the Skin","author":"Lever","year":"1990","edition":"7th"},{"issue":"2","key":"2025051303321543200_ref31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"issue":"3","key":"2025051303321543200_ref32","first-page":"269","article-title":"The female sexual function index (fsfi): validation of the Iranian version","volume":"7","author":"Mohammadi","year":"2008","journal-title":"PAYESH"},{"issue":"8","key":"2025051303321543200_ref33","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/humrep\/dem108","article-title":"Quality of life and psychological well being in polycystic ovary syndrome","volume":"22","author":"Barnard","year":"2007","journal-title":"Hum Reprod"},{"issue":"9","key":"2025051303321543200_ref34","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/humrep\/des199","article-title":"Psychometric properties of the Iranian version of modified polycystic ovary syndrome health-related quality-of-life questionnaire","volume":"27","author":"Bazarganipour","year":"2012","journal-title":"Hum Reprod"},{"issue":"1","key":"2025051303321543200_ref35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","article-title":"International experiences with the hospital anxiety and depression scale: a review of validation data and clinical results","volume":"42","author":"Herrmann","year":"1997","journal-title":"J Psychosom Res"},{"issue":"1","key":"2025051303321543200_ref36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-7525-1-14","article-title":"The hospital anxiety and depression scale (HADS): translation and validation study of the Iranian version","volume":"1","author":"Montazeri","year":"2003","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"2025051303321543200_ref37","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.fertnstert.2005.10.043","article-title":"Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study","volume":"85","author":"Caruso","year":"2006","journal-title":"Fertil Steril"},{"issue":"2","key":"2025051303321543200_ref38","first-page":"61","article-title":"The impact of polycystic ovary syndrome on the health-related quality of life: a systematic review and meta-analysis","volume":"13","author":"Bazarganipour","year":"2015","journal-title":"Iran J Reprod Med"},{"issue":"5","key":"2025051303321543200_ref39","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.26355\/eurrev_202403_35605","article-title":"Measures of health-related quality of life in PCOS women: a cross sectional study from Saudi Arabia","volume":"28","author":"AlAhmari","year":"2024","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"2025051303321543200_ref40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000535565","article-title":"Higher depressive symptoms in irregular menstrual cycles: converging evidence from cross-sectional and prospective assessments","volume":"57","author":"Klusmann","year":"2024","journal-title":"Psychopathology"},{"issue":"2","key":"2025051303321543200_ref41","doi-asserted-by":"publisher","first-page":"e12423","DOI":"10.5812\/ircmj.12423","article-title":"Female gender scheme is disturbed by polycystic ovary syndrome: a qualitative study from Iran","volume":"16","author":"Nasiri Amiri","year":"2014","journal-title":"Iran Red Crescent Med J"},{"issue":"2","key":"2025051303321543200_ref42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/26895269.2023.2183448","article-title":"The double-edged sword of PCOS and gender: exploring gender-diverse experiences of polycystic ovary syndrome","volume":"25","author":"Wugalter","year":"2023","journal-title":"Int J Transgend Health"},{"issue":"11","key":"2025051303321543200_ref43","doi-asserted-by":"publisher","first-page":"e49146","DOI":"10.7759\/cureus.49146","article-title":"The impact of irregular menstruation on health: a review of the literature","volume":"15","author":"Attia","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"2025051303321543200_ref44","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12905-018-0658-1","article-title":"Polycystic ovary syndrome and its impact on Iranian women's quality of life: a population-based study","volume":"18","author":"Behboodi Moghadam","year":"2018","journal-title":"BMC Womens Health"},{"issue":"4","key":"2025051303321543200_ref45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.22074\/ijfs.2015.4181","article-title":"The social consequences of infertility among Iranian women: a qualitative study","volume":"8","author":"Hasanpoor-Azghdy","year":"2015","journal-title":"Int J Fertil Steril"},{"issue":"1","key":"2025051303321543200_ref46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12905-015-0272-4","article-title":"Health-related quality of life in Iranian women with polycystic ovary syndrome: a qualitative study","volume":"15","author":"Taghavi","year":"2015","journal-title":"BMC Womens Health"},{"issue":"1","key":"2025051303321543200_ref47","doi-asserted-by":"publisher","first-page":"2218987","DOI":"10.1080\/0167482X.2023.2218987","article-title":"Experience of mental health in women with polycystic ovary syndrome: a descriptive phenomenological study","volume":"44","author":"Wang","year":"2023","journal-title":"J Psychosom Obstet Gynecol"},{"key":"2025051303321543200_ref48","doi-asserted-by":"publisher","DOI":"10.4324\/9780203167977","volume-title":"Family Planning in the Legacy of Islam","author":"Omran","year":"2012"},{"issue":"04","key":"2025051303321543200_ref49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2307\/1160093","article-title":"Sex, fertility and menstruation among the Beng of the Ivory Coast: a symbolic analysis","volume":"52","author":"Gottlieb","year":"1982","journal-title":"Africa"},{"issue":"10","key":"2025051303321543200_ref50","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/humrep\/deh432","article-title":"Infertility caused by PCOS--health-related quality of life among Austrian and Moslem immigrant women in Austria","volume":"19","author":"Schmid","year":"2004","journal-title":"Hum Reprod"},{"issue":"3","key":"2025051303321543200_ref51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1359105303008003004","article-title":"Hirsutism: a psychological analysis","volume":"8","author":"Keegan","year":"2003","journal-title":"J Health Psychol"},{"issue":"6","key":"2025051303321543200_ref52","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1530\/eje.1.02024","article-title":"Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome","volume":"153","author":"Hahn","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025051303321543200_ref53","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1159\/000339118","article-title":"Female sexual dysfunction in type 2 diabetes: a case control study","volume":"21","author":"Sharifiaghdas","year":"2012","journal-title":"Med Princ Pract"},{"issue":"3","key":"2025051303321543200_ref54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/01.ogx.0000157978.91721.0f","article-title":"Female sexual dysfunction: principles of diagnosis and therapy","volume":"60","author":"Pauls","year":"2005","journal-title":"Obstet Gynecol Surv"},{"issue":"1","key":"2025051303321543200_ref55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00926230590475206","article-title":"The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores","volume":"31","author":"Wiegel","year":"2005","journal-title":"J Sex Marital Ther"},{"key":"2025051303321543200_ref56","first-page":"1","article-title":"Comparative study on women's sexual functioning disorders before and after menopause","volume":"3","author":"Arman","year":"2006","journal-title":"J Arak Univ Med Sci"},{"issue":"5","key":"2025051303321543200_ref57","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/GME.0b013e3182a6c8f3","article-title":"Melatonin in perimenopausal and postmenopausal women: associations with mood, sleep, climacteric symptoms, and quality of life","volume":"21","author":"Toffol","year":"2014","journal-title":"Menopause"},{"issue":"1","key":"2025051303321543200_ref58","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1196\/annals.1356.030","article-title":"Effects of melatonin in perimenopausal and menopausal women: our personal experience","volume":"1057","author":"Bellipanni","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"07","key":"2025051303321543200_ref59","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4236\/ijcm.2012.37104","article-title":"Depression and insulin resistance in non-diabetic subjects: an intervention study with insulin clamp technique","volume":"03","author":"Asghar","year":"2012","journal-title":"International Journal of Clinical Medicine"},{"issue":"4","key":"2025051303321543200_ref60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4088\/pcc.v06n0402","article-title":"The metabolic syndrome in patients with severe mental illnesses","volume":"6","author":"Toalson","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"9","key":"2025051303321543200_ref61","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3390\/brainsci13091262","article-title":"Exploring the relationship between mood disorders and coexisting health conditions: the focus on nutraceuticals","volume":"13","author":"Mechli\u0144ska","year":"2023","journal-title":"Brain Sci"},{"issue":"6","key":"2025051303321543200_ref62","first-page":"493","article-title":"Mode of action of sildenafil","volume":"21","author":"Wang","year":"1999","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"10","key":"2025051303321543200_ref63","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1111\/cns.14358","article-title":"Sildenafil and depression: true or false prophecy","volume":"29","author":"Al-Kuraishy","year":"2023","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"6","key":"2025051303321543200_ref64","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.2047-2927.2013.00131.x","article-title":"Sildenafil increases serum testosterone levels by a direct action on the testes","volume":"1","author":"Spitzer","year":"2013","journal-title":"Andrology"},{"issue":"10","key":"2025051303321543200_ref65","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1111\/cns.14358","article-title":"Sildenafil and depression: true or false prophecy","volume":"29","author":"Al-Kuraishy","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"2025051303321543200_ref66","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejphar.2018.10.032","article-title":"Melatonin activates BKCa channels in cerebral artery myocytes via both direct and MT receptor\/PKC-mediated pathway","volume":"842","author":"Xu","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"2025051303321543200_ref67","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/biom10091211","article-title":"Melatonin's impact on Antioxidative and anti-inflammatory reprogramming in homeostasis and disease","volume":"10","author":"Chitimus","year":"2020","journal-title":"Biomol Ther"},{"issue":"13","key":"2025051303321543200_ref68","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2147\/DMSO.S242208","article-title":"Antioxidant and anti-inflammatory properties of melatonin in patients with type 2 diabetes mellitus with periodontal disease under non-surgical periodontal therapy: a double-blind","author":"Zare","year":"2020","journal-title":"Placebo-Controlled Trial Diabetes Metab Syndr Obes"},{"issue":"1-2","key":"2025051303321543200_ref69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/s0006-8993(00)02715-3","article-title":"Acute low doses of melatonin restore full sexual activity in impotent male rats","volume":"878","author":"Drago","year":"2000","journal-title":"Brain Res"},{"issue":"1","key":"2025051303321543200_ref70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0304-3940(01)01930-9","article-title":"Melatonin reduces anxiety induced by lipopolysaccharide in the rat","volume":"307","author":"Nava","year":"2001","journal-title":"Neurosci Lett"},{"issue":"4","key":"2025051303321543200_ref71","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/s0031-9384(99)00204-8","article-title":"Melatonin enhances sexual behavior in the male rat","volume":"68","author":"Brotto","year":"2000","journal-title":"Physiol Behav"},{"issue":"20","key":"2025051303321543200_ref72","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.18632\/aging.102367","article-title":"Melatonin induces progesterone production in human granulosa-lutein cells through upregulation of StAR expression","volume":"11","author":"Fang","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"2025051303321543200_ref73","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/humrep\/10.1.50","article-title":"Melatonin and steroids in human pre-ovulatory follicular fluid: seasonal variations and granulosa cell steroid production","volume":"10","author":"Yie","year":"1995","journal-title":"Hum Reprod"},{"issue":"4","key":"2025051303321543200_ref74","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11930-022-00347-6","article-title":"The relationship between sleep and sexual function in women","volume":"14","author":"Al-Badri","year":"2022","journal-title":"Curr Sex Health Rep"},{"issue":"6","key":"2025051303321543200_ref75","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/GME.0000000000000824","article-title":"Association of sleep disturbance and sexual function in postmenopausal women","volume":"24","author":"Kling","year":"2017","journal-title":"Menopause"},{"key":"2025051303321543200_ref76","doi-asserted-by":"publisher","first-page":"1184745","DOI":"10.3389\/fendo.2023.1184745","article-title":"Protective effects of exogenous melatonin therapy against oxidative stress to male reproductive tissue caused by anti-cancer chemical and radiation therapy: a systematic review and meta-analysis of animal studies","volume":"14","author":"Dehdari","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2025051303321543200_ref77","first-page":"199","article-title":"Effect of melatonin on sexual behavior in male diabetic rats","volume":"11","author":"Babaei","year":"2010","journal-title":"Iranian Journal of Endocrinology and Metabolism"},{"issue":"8","key":"2025051303321543200_ref78","doi-asserted-by":"publisher","first-page":"e44493","DOI":"10.7759\/cureus.44493","article-title":"Role of metformin in polycystic ovary syndrome (PCOS)-related infertility","volume":"15","author":"Attia","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"2025051303321543200_ref79","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/2042018810380215","article-title":"Role of metformin in the management of polycystic ovary syndrome","volume":"1","author":"Lashen","year":"2010","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"4","key":"2025051303321543200_ref80","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/s0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil Steril"},{"issue":"1","key":"2025051303321543200_ref81","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/humrep\/15.1.21","article-title":"Metformin treatment reduces ovarian cytochrome P-450c17\u03b1 response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome","volume":"15","author":"la Marca","year":"2000","journal-title":"Hum Reprod"},{"issue":"3","key":"2025051303321543200_ref82","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/2042018810380215","article-title":"Role of metformin in the management of polycystic ovary syndrome","volume":"1","author":"Lashen","year":"2010","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"8","key":"2025051303321543200_ref83","doi-asserted-by":"publisher","first-page":"e44493","DOI":"10.7759\/cureus.44493","article-title":"Role of metformin in polycystic ovary syndrome (PCOS)-related infertility","volume":"15","author":"Attia","year":"2023","journal-title":"Cureus."},{"issue":"8","key":"2025051303321543200_ref84","first-page":"18123","article-title":"Effectiveness of melatonin in combination with sildenafil in treatment of intrauterine growth restriction: a double-blind, randomized clinical trial","volume":"11","author":"Taj Aramesh","year":"2023","journal-title":"Journal of Pediatric Perspectives"},{"issue":"2","key":"2025051303321543200_ref85","doi-asserted-by":"publisher","first-page":"CD006490","DOI":"10.1002\/14651858.CD006490","article-title":"Nitric oxide for preventing pre-eclampsia and its complications","volume":"2010","author":"Meher","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"2025051303321543200_ref86","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1097\/MS9.0000000000002350","article-title":"Effect of melatonin as a therapeutic strategy against intrauterine growth restriction: a mini-review of current state","volume":"86","author":"Rashidi","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"2025051303321543200_ref87","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1250134","article-title":"Dousing the flame: reviewing the mechanisms of inflammatory programming during stress-induced intrauterine growth restriction and the potential for \u03c9-3 polyunsaturated fatty acid intervention","volume":"14","author":"White","year":"2023","journal-title":"Front Physiol"},{"issue":"1","key":"2025051303321543200_ref88","first-page":"734865","article-title":"Intrauterine growth restriction: cytokine profiles of trophoblast antigen-stimulated maternal lymphocytes","volume":"2012","author":"Raghupathy","year":"2012","journal-title":"J Immunol Res"},{"issue":"6","key":"2025051303321543200_ref89","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.2337\/dc11-9998","article-title":"National Academy of Clinical Biochemistry. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"34","author":"Sacks","year":"2011","journal-title":"Diabetes Care"},{"issue":"4","key":"2025051303321543200_ref90","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and Management of Polycystic Ovary Syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"issue":"1","key":"2025051303321543200_ref91","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1472-6823-13-47","article-title":"Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study","volume":"13","author":"Gayoso-Diz","year":"2013","journal-title":"BMC Endocr Disord"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/5\/813\/62456607\/qdaf028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/5\/813\/62456607\/qdaf028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:32:26Z","timestamp":1747121546000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/22\/5\/813\/8086865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":91,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3,19]]},"published-print":{"date-parts":[[2025,5,10]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdaf028","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,3,19]]}}}